Zepbound vs Wegovy Cost in 2026: Full Price Comparison
Price verification — October 26, 2026
This article includes an older pricing snapshot. Older amounts, coupons and annual totals below are historical illustrations, not current checkout quotes.
- Zepbound (tirzepatide): LillyDirect self-pay: 2.5 mg starts at $299/28 days, 5 mg at $399, and 7.5 mg and above at $449 only with qualifying 45-day refill timing. Higher-dose prices can be higher when those conditions are not met. Supplies may cost extra. Official source
- Wegovy (semaglutide): Wegovy tablet: $149/30 tablets at 1.5 mg, $199 at 4 mg (a temporary $149 4 mg offer may apply), and $299 at 9 mg or 25 mg. Wegovy injection: eligible new patients may pay $199 per 28-day fill for the first two fills at 0.25 or 0.5 mg through Dec. 31, 2026, then generally $349 for standard pen doses. Eligibility and dosage restrictions apply. Official source
- Clinical program fees: Ivím lists a $74.99/month membership with medication billed separately. Sesame lists care from $59/month on a 12-month commitment; month-to-month costs more, and medication is separate. These are care fees, not all-inclusive drug prices. Official source
- Sesame annual-commitment terms: Official source.
These are manufacturer self-pay or listed care-fee examples, not one all-inclusive price or guaranteed prescription. Insurers, clinical visits, pharmacy choice, dosage, supplies, refill conditions and geography can change the amount due.
Key Takeaways
- Wegovy is cheaper at every self-pay tier — $149/month (pill) vs. Zepbound's $299/month entry
- At maintenance doses: Wegovy pen $349/month vs. Zepbound $449/month
- Both cost $50/month through Medicare Bridge and $25/month with commercial insurance + savings card
- Clinical trials show tirzepatide (Zepbound) produces ~5–7% more weight loss than semaglutide (Wegovy) on average
- 12-month self-pay total: Wegovy pill ~$3,190 vs. Zepbound ~$5,039
Wegovy and Zepbound are the two dominant GLP-1 weight loss medications in 2026, and "which one is cheaper?" is one of the most common questions people ask before starting treatment. The short answer: Wegovy costs less at every self-pay price point. The longer answer: the clinical difference might justify Zepbound's premium for some patients.
This guide compares every cost pathway side by side.
Full Price Comparison: Every Pathway
| Access Pathway | Wegovy | Zepbound | Difference |
|---|---|---|---|
| Cheapest self-pay entry | $149/mo (pill) | $299/mo | Wegovy saves $150 |
| Injection entry (intro) | $199/mo* | $299/mo | Wegovy saves $100 |
| Injection maintenance | $349/mo | $449/mo | Wegovy saves $100 |
| High dose | $399/mo (7.2 mg) | $449/mo (15 mg) | Wegovy saves $50 |
| Subscription (3-month) | $329/mo | N/A | Wegovy only |
| Insurance + savings card | $25/mo | $25/mo | Tied |
| Medicare Bridge | $50/mo | $50/mo | Tied |
| TrumpRx | ~$199–$350 | ~$299–$346 | Comparable |
| List price (retail) | $1,349/mo | $1,086/mo | Zepbound lower list |
*Wegovy $199 intro for first 2 months on starter doses through 8/31/2026. Zepbound 45-day refill rule applies on 7.5 mg+ doses.
12-Month Cost Comparison
| Scenario | Wegovy Pill | Wegovy Pen | Zepbound (LillyDirect) |
|---|---|---|---|
| 12-month total (self-pay) | ~$3,190 | ~$3,892 | ~$5,039 |
| 12-month total (Medicare) | $600 | $600 | $600 |
| 12-month total (insured) | $300 | $300 | $300 |
The Clinical Trade-Off
Zepbound's higher price reflects a real clinical difference: tirzepatide is a dual GIP/GLP-1 receptor agonist that targets two hunger-signaling pathways, while Wegovy (semaglutide) targets one. In head-to-head-adjacent trial data, tirzepatide produced approximately 5–7% more total body weight loss than semaglutide at their respective maximum doses.
Whether that additional weight loss is worth $100–$150/month more depends on your goals, your starting point, and how you respond to each medication. Some patients do better on one than the other regardless of average trial results.
Which Should You Choose?
Choose Wegovy if: Budget is a top priority, you want the oral pill option ($149/month entry), or your insurance covers Wegovy but not Zepbound.
Choose Zepbound if: Maximum weight loss is the priority, you can afford $449/month, or your insurance covers Zepbound (making the cost equal).
If you have insurance or Medicare: The cost is the same ($25 or $50/month). In that case, discuss clinical fit with your doctor — let efficacy and side-effect profiles guide the decision, not price.
Injectable semaglutide
Compounded medications are prepared by pharmacies and are not FDA-approved. They have not been evaluated for safety, efficacy, or manufacturing quality by the FDA.
Paid link · We may earn a commission
Explore available weight-management program types and confirm the exact medication, pharmacy and recurring charges.
Explore GobyMeds ↗Medication, legal availability, provider credentials and full price require verification; compounded medications are not FDA-approved.Wegovy is the cheaper option at every self-pay tier, saving $100–$150/month vs. Zepbound. Over a year, that's $1,150–$1,850 in savings. The clinical case for Zepbound (more weight loss on average) is real but doesn't change the math for most budget-conscious patients. If insurance or Medicare equalizes the cost, let your doctor guide the clinical decision.
Prices verified as of July 15, 2026. Clinical comparisons reference STEP (semaglutide) and SURMOUNT (tirzepatide) trial programs. This is not medical advice.